A director at Veracyte Inc sold 10,739 shares at 43.133USD and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...
A director at Consumer Portfolio Services Inc sold 100,000 shares at 8.690USD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
Back to Near-Term Bullish on SPX and QQQ We downgraded our near-term outlook on the S&P 500 (SPX) and Nasdaq 100 (QQQ) to neutral last week (11/19/25 Compass), after being bullish since our 4/22/25 Compass, while maintaining our intermediate-term bullish outlook (as of our 5/14/25 Compass). Crucial support levels of 6480-6520 on SPX and $580-$583 on QQQ held last week, and we are right back to being near-term bullish as long as these support levels continue to hold. Just know that SPX could see...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
n this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
CPS Announces Third Quarter 2025 Earnings Revenues of $108.4 million compared to $100.6 million in the prior year periodPretax income of $7.0 million compared to $6.9 million in the prior year periodNew contract purchases of $391.1 million in the quarter LAS VEGAS, NV, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced earnings of $4.9 million, or $0.20 per diluted share, for its third quarter ended September 30, 2025. This represents an increase compared to net income of $4.8 million, or $0.20 per diluted share, in...
CPS to Host Conference Call on Third Quarter 2025 Earnings LAS VEGAS, Nevada, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced that it will hold a conference call on Tuesday, November 11, 2025 at 1:00 p.m. ET to discuss its third quarter 2025 operating results. Those wishing to participate can pre-register for the conference call at the following link . Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, we encourage participants to dial into the c...
CPS Announces Closing of $167.5 Million Credit Facility LAS VEGAS, Nevada, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”) today announced that on October 17, 2025, it closed a new two-year revolving credit agreement. Loans under the credit agreement will be secured by automobile receivables that CPS now holds or will purchase from dealers in the future. The credit facility includes a subordinate lender that will provide a higher effective advance rate for the facility. CPS may borrow on a revolving basis through October 2027, a...
89bio, Inc. Announces Agreement to be Acquired by Roche – 89bio stockholders to receive up to $20.50 per share in cash, comprised of $14.50 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $6.00 per share in cash; transaction represents total equity value of up to approximately $3.5 billion – – Transaction reflects pegozafermin’s potential best-in-disease profile for the treatment of moderate to severe metabolic dysfunction-associated steatohepatitis (MASH) – – 89bio to join the Roche Group as part of Roche’s Pharmaceutical...
Mount Logan Capital Inc. Begins Trading on Nasdaq Under “MLCI” Trading commenced on the Nasdaq Capital Market September 15, following the September 12 closing of the Business Combination NEW YORK, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Mount Logan Capital Inc. (Nasdaq: MLCI) (“Mount Logan” or the “Company”) is pleased to announce that its common stock began trading on the Nasdaq Capital Market on Monday, September 15, 2025, under the ticker symbol “MLCI.” The start of trading follows the successful closing of Mount Logan’s strategic, all-stock Business Combination with 180 Degree Capital Co...
Mount Logan Capital Inc. and 180 Degree Capital Corp. Close Strategic Business Combination Establishes U.S.-based alternative asset management and insurance solutions platform Merged Company, Mount Logan Capital Inc., expected to begin trading on NASDAQ under the symbol “MLCI” on Monday, September 15, 2025 Closing Merger Value of approximately US$122.7 million equates to a price per share of MLCI of US$9.43 NEW YORK and MONTCLAIR, N.J., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Mount Logan Capital Inc. (“Mount Logan”) and 180 Degree Capital Corp. (“180 Degree Capital”) (Nasdaq: TURN) today an...
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SAN FRANCISCO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Compensation Committee of the Company’s Board of Directors approved the grant of non-qualified stock options to purchase an aggregate of 64,750 shares of the Company’s common stock to three new employees (the “Inducement ...
89bio to Participate in Upcoming Investor Conferences SAN FRANCISCO, Aug. 28, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced that the Company’s management will participate in the following investor conferences during the month of September: Citi’s 2025 Biopharma Back to School ConferenceFormat:Fireside ChatDate:Wednesday, September 3, 2025Time:11:15 AM EDT Cantor Global Healthcare Conference 2025...
Consumer Portfolio Services to Present at the 2025 Gateway Conference on September 3rd LAS VEGAS, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Consumer Portfolio Services, Inc. (Nasdaq: CPSS) (“CPS” or the “Company”), a leader in providing indirect automobile financing to consumers, is confirmed to present at the , which is being held September 3–4 at the in San Francisco, CA. CPS’ management team is scheduled to present on Wednesday, September 3rd at 1:30 p.m. Pacific Time (PT). The presentation will be webcast live and available for replay . In addition to the presentation, CPS executives ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.